Janet Leandro Marmolejo | Bacterial Microbiology | Research Excellence Award

Assist. Prof. Dr. Janet Leandro Marmolejo | Bacterial Microbiology | Research Excellence Award

Researcher | Postgraduate College | Mexico

Assist. Prof. Dr. Janet Leandro Marmolejo is a dynamic researcher and laboratory scientist with a robust focus on microbiology, molecular biology, genetics, and livestock production. Her research expertise spans animal parasitology, pathology, and sustainable livestock systems, with a particular interest in the secondary metabolism of bacterial strains and their pharmacological potential. She has led innovative projects, including the development of a biotechnological process for the synthesis of Ivermectin B1b using Streptomyces avermitilis through submerged fermentation, as well as studies on reproductive and productive indicators in buffalo and turkey populations. Assist. Prof. Dr. Janet Leandro Marmolejo work emphasizes the integration of microbiological, genetic, and biotechnological approaches to improve livestock health, productivity, and well-being while addressing challenges related to animal diseases and sustainable agricultural practices. She has contributed to standardizing analytical techniques for the verification of secondary metabolites, establishing bacterial strain collections, and optimizing biotechnological methodologies that form solid foundations for future research in microbiology and molecular biology. Assist. Prof. Dr. Janet Leandro Marmolejo actively disseminates her findings through peer-reviewed publications, scientific conferences, and seminars, and she participates as a volunteer reviewer and collaborator in multidisciplinary research projects. Her dedication extends to animal welfare, feed management, and practical applications of microbiological and genetic insights in agronomic systems, reflecting a commitment to advancing livestock science, sustainable animal production, and innovative biotechnological solutions within agricultural research.

Profiles: Google Scholar | Orcid

Featured Publications

Marmolejo, J. L., Crosby Galván, M. M., Crosby Galván, E. M., Vallejo Hernández, L. H., Sánchez-Torres Esqueda, M. T., Cortez Romero, C., & Améndola Massiotti, R. D. (2025, November 27). The metabolism of Streptomyces avermitilis isolated from agricultural soils during the four seasons of the year. Applied Microbiology.

Marmolejo, J., & Ahedo, A. (2023, December). Methods for rotation of sanitary calendars in Suffolk breed fattening sheep pens. Universidad Autónoma Chapingo.

Marmolejo, J. (2023, June 30). Determination of reproductive morphometric indicators in male water buffalo (Bubalus bubalis) through andrological examination using the electro-ejaculator in Costa Rica. 4th National Student Congress on Biology, Environmental Education, and Organic Agriculture.

Marmolejo, J. (2023, June 28). Ethological evaluation in two types of environments and their productive response in double-breasted turkeys (Meleagris gallopavo Linn). 4th National Student Congress on Biology, Environmental Education, and Organic Agriculture.

Hiba Akram | Microbiology | Young Scientist Award

Mrs. Hiba Akram | Microbiology | Young Scientist Award

Senior Lecturer | Shalamar Institute of Health Sciences | Pakistan

Mrs. Hiba Akram is a dedicated researcher and Senior Lecturer in Medical Laboratory Technology whose work spans microbiology, infectious diseases, biotechnology, nutrigenomics, and precision medicine. Her academic and scientific journey reflects a deep commitment to advancing laboratory sciences through high-quality research, evidence-based practice, and innovation in clinical diagnostics. She has contributed to impactful projects exploring enzyme technology, antibiotic resistance, microbial behavior under stress conditions, nutrigenomic interactions in obesity, and cytomorphological patterns in endocrine disorders. Her completed work includes investigations on nano-coupled thermostable enzymes, plasmid elimination dynamics, and diagnostic cytology, while her ongoing studies address public health challenges such as obesity trends, burn wound microbiology, and hygiene-associated infections. Mrs. Hiba Akram has published research in reputable national and international journals and has authored a chapter in a scientific book, further strengthening her growing academic footprint. Her collaborative engagements with leading academic and healthcare institutions support multidisciplinary research, curriculum enhancement, and student mentorship, and she actively participates in international conferences to disseminate findings and expand scientific dialogue. Her research interests continue to evolve toward the intersection of microbiology, biotechnology, and personalized health, integrating genomic and microbial insights to improve clinical outcomes. Through her contributions to teaching, scholarly writing, and innovative research, she remains committed to shaping the future of Medical Laboratory Technology and advancing scientific understanding in fields critical to public health and biomedical science.

Profiles: Scopus | Orcid | Researchgate | Google Scholar

Featured Publications

Gohar, U. F., Shah, Z., Sarwar, J., Akram, H., & Mukhtar, H. (2021). Recent advances in biotechnology in animal health. Veterinary Pathobiology and Public Health, Unique Scientific Publishers, 7.

Farzand, A., Rohin, M. A. K., Awan, S. J., Ahmad, A. M. R., Akram, H., Saleem, T., … (2025). Nutrigenomics of obesity: Integrating genomics, epigenetics, and diet–microbiome interactions for precision nutrition. Life, 15(11), 1658.

Naseer, M. U., Bilal, M., Sonum, S., Kaleem, M., Akram, H., Altaf, Y., Rafeeq, A., … (2025). Cytomorphological spectrum of thyroid nodules diagnosed by fine-needle aspiration cytology in a tertiary care center. Insights – Journal of Life and Social Sciences, 3(3), 180–188.

Akram, H., Shahid, S., Bukhari, H., Iqbal, K., & Asif, M. (2022). Impact of antibiotic withdrawal and starvation conditions on plasmid elimination and consequent loss of resistance. JPMA: The Journal of the Pakistan Medical Association, 72(6), 1053–1056.

Dr. Nitin Pal Kalia | Immunology and Microbiology | Best Researcher Award

Dr. Nitin Pal Kalia | Immunology and Microbiology | Best Researcher Award

Dr. Nitin Pal Kalia, Assistant Professor, National Institute of Pharmaceutical Education and Research Hyderabad, India

🌟 Dr. Nitin Pal Kalia 🌟, an esteemed Assistant Professor at the National Institute of Pharmaceutical Education and Research, Hyderabad, India, is renowned for his groundbreaking research in Immunology and Microbiology 🧬🔬. His innovative work has earned him the prestigious Best Researcher Award 🏆, recognizing his significant contributions to the scientific community 🌐. Dr. Kalia’s research focuses on understanding the immune system’s complexities and developing novel therapeutic strategies to combat infectious diseases 💉🦠. His dedication to advancing pharmaceutical education and research has made him a prominent figure in his field 📚🎓.

👩‍🎓 Profile

Googlescholar, Orcid

📚  Education

🎓 Dr. Nitin Pal Kalia earned his Ph.D. in Biotechnology from the Indian Institute of Integrative Medicine, Jammu, India, under the guidance of Dr. Inshad Ali Khan, Sr. Principal Scientist, from October 2007 to January 2014 🧪. He previously completed his M.Sc. in Biotechnology at Guru Nanak Dev University, Amritsar, Punjab, India, from June 2004 to May 2006, after qualifying the CEEB examination conducted by JNU 🧬. Dr. Kalia’s academic journey reflects his dedication to the field of Clinical Microbiology and Biotechnology 📚🔬.

🔬 Research Experience

📚 Dr. Nitin Pal Kalia is an esteemed Assistant Professor at NIPER, Hyderabad, Telangana, India, since February 4, 2021. 🌟 Previously, he was honored with the Ramalingaswami Fellowship by the Department of Biotechnology, serving at CSIR-IIIM Jammu from August 16, 2019, to February 1, 2021. 🎓 He was a Research Fellow at Lee Kong Chian School of Medicine, NTU Singapore, from October 16, 2015, to August 15, 2019. 🌏 Dr. Kalia also gained valuable experience as a Visiting Fellow at NIAID-NIH Bethesda, USA, from May 16, 2014, to July 31, 2015. 🌟👏

🎓 Trainings

Dr. Nitin Pal Kalia has impressive experience in biotech research. From February to July 2007, he worked as a trainee on a project titled “Cloning and recombinant expression of Rhabdovirus antigens for vaccine development” at Bharat Biotech International Private Limited in Hyderabad under the Biotech Industrial Training Program sponsored by the Department of Biotechnology, Govt. of India 🧬💉. Additionally, from June to July 2005, he was a trainee on a project entitled “Identifying Bacterial Diversity in Natural Environment: a molecular phylogenetic approach” at IHBT-CSIR in Palampur, Himachal Pradesh 🌿🔬.

🏆 Accomplishments

Dr. Nitin Pal Kalia has a distinguished record in biosafety and research. 🏆 He was awarded the Ramalingaswami Re-entry Fellowship (2017-2018) by DBT, India. His expertise includes BSL-3 training from the National University of Singapore (2016) and NIH USA (2014 & 2015). 🧪 He completed hands-on training on laboratory animal care with A*Star Singapore (2015) and holds the IIIM-CSIR award for novel tuberculosis scaffolds (2013). 🦠 Dr. Kalia also received the ICMR-Senior Research Fellowship for his work on Staphylococcus aureus (2010) and was sponsored by DBT for industrial training (2007). 🧬 He qualified JNU’s Biotechnology Entrance Exam in 2004. 🎓

🔬 Doctoral Research & Post-Doctoral Research

Dr. Nitin Pal Kalia focuses on innovative approaches to combat drug-resistant Mycobacterium tuberculosis. His research explores targeting terminal oxidases and cell wall synthesis. Key findings include the use of Q203 to inhibit the respiratory cytochrome bc1 complex and ongoing efforts to identify potent inhibitors for the bd-oxidase. At NIH, he evaluated new chemical entities, profiling them against resistant MTb mutants. During his Ph.D., he discovered capsaicin as an inhibitor of the NorA efflux pump, significantly reducing the invasiveness of Staphylococcus aureus in macrophages. 💊🔬🦠🔍

🔧 Workshops

🌟 Dr. Nitin Pal Kalia has participated in significant workshops, enhancing his expertise in biotechnology and regulatory toxicology. He attended a workshop on “Management of IPR in Biotechnology” in Hyderabad, sponsored by the Department of Biotechnology, Government of India (April 26-27, 2007) 🌱🔬. Additionally, he engaged in an online national workshop on ‘Role of Regulatory Toxicology and Good Laboratory Practice (GLP) in Drug Discovery and Development’ conducted by NIPER, Hyderabad (August 27-28, 2020) 💻💊. These experiences have enriched his knowledge and professional growth in these crucial fields. 📚✨

📝 Abstracts presented in conferences

Dr. Nitin Pal Kalia has made significant contributions to the field of medicinal chemistry. His research includes a 2022 study, where he explored how capsaicin boosts mupirocin’s efficacy against Staphylococcus aureus by inhibiting the MdeA efflux pump. 🧪🔬 In 2013, Dr. Kalia identified novel inhibitors for the multidrug-resistant efflux pump Rv1258c in Mycobacterium tuberculosis. 🦠🔍 His 2010 study highlighted how piperine enhances rifampicin’s protective efficacy against Mycobacterium tuberculosis infection, showcasing its immunomodulatory activity. 🌿🛡️ His work underscores a commitment to advancing antimicrobial and immunomodulatory therapies. 👩‍🔬👨‍🔬

📄 Publications Top Notes

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection

Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors

Sulfur rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents

Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus

Protective efficacy of piperine against Mycobacterium tuberculosis

Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit

Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer

Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and …

Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis